Biotech, Food, Drug

The food we eat and the medicine we put into our bodies are highly regulated by a variety of government agencies. In the United States by the Food and Drug Administration (FDA) and the United States Department of Agriculture (USDA) regulate the processes by which food makes its way to the grocery store and medicine is approved for consumer use.  As the science grows more complex behind the pharmaceutical and food industry, interpretation of the regulations in place is becoming more nuanced.  Overseas, these industries are regulated by a variety of agencies; for example, the Minister of Agriculture in Canada, Centre for Food Safety in Hong Kong, and the Committee of Environmental, Public Health and Food Safety (EU), are among the many governing-bodies which regulate biotechnology, food, and drugs throughout the world.

The National Law Review is your free online resource to agency news, emerging topics in food and drug, and the latest in biotechnology updates. From nanotechnologies being used in research, to regulations of imported foods coming into the US from overseas or the development of medical devices and drugs, readers can find expert legal analysis of the developments in the industry, as well as reports on changes within the agencies that regulate these industries. The National Law Review also covers topics related to licensing, Food Safety and Inspection Services (FSIS), food and beverage regulation in the US and worldwide, nutrition labeling, and country of origin labeling guidelines.

With recent legislation being passed throughout the US in relation to marijuana use, both for recreational and medicinal purposes, readers will also find up-to-date information, litigation, and news coming from this area of interest as well. Regulations in California for labeling and proper sales of marijuana, to use in different states, or internationally, as well as rules for promoting and advertising marijuana are also covered on the site. Additionally, the development and changing landscape of tobacco use to include vaping, and how e-cigarettes and vaping are regulated, is also covered by NLR authors.

Readers who are interested in food safety, inspection, imports into the US, and regulations, these topics are covered regularly on The National Law Review as well. New legislation from the FDA, USDA, Department of Agriculture, and international bodies, are covered on the site. If you are looking for details on new nutrition-labeling regulations or health risks of consuming certain imported foods, you will find these topics, and many more, on The National Law Review.

For hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Organization Sort descending
Nov
12
2016
Center for Medical Device Evaluation of China Food and Drug Administration Releases New Inquiry Rules on Medical Device Technical Review Covington & Burling LLP
Aug
3
2017
FDA Releases Details and Timelines in Its Digital Health Innovation Action Plan Covington & Burling LLP
Mar
16
2018
Oregon HB 4005: New Reporting Requirements for Drug Manufacturers, Health Insurers Covington & Burling LLP
May
10
2018
The 340B Ceiling Price and CMP Rule . . . Changes on the Horizon? Covington & Burling LLP
Jun
10
2014
FDA Launches OpenFDA To Ease Access to FDA Datasets — Which Creates Opportunities for Developers of Mobile Medical Apps Covington & Burling LLP
Jul
1
2014
FDA (Food and Drug Administration) Issues Long-Awaited Draft Guidance Documents Concerning Internet/Social Media Covington & Burling LLP
Jul
9
2014
Confronting Apocalyptic Risks of Broken Antibiotics Pipeline Covington & Burling LLP
Aug
11
2014
MHRA creates new expert advisory group on medical devices Covington & Burling LLP
Sep
20
2014
Court Rejects FDA’s Interpretation of the Statute’s Device Definition as “Erroneous and Unreasonable” Covington & Burling LLP
Oct
29
2014
Recent Trends in Medical Device Patent Litigation at the ITC — Part 1 Covington & Burling LLP
Feb
5
2015
President’s Budget Includes Funding for Precision Medicine Initiative Covington & Burling LLP
Feb
10
2015
Important Developments in FDA Regulation of Software, Including Mobile Apps Covington & Burling LLP
Apr
21
2015
FDA Issues Draft Guidance Concerning the Use of Electronic Informed Consent in Clinical Investigations Covington & Burling LLP
Dec
22
2015
Comprehensive Amendments of German Drug Laws upcoming Covington & Burling LLP
Aug
3
2017
FDA Initiates Software Precertification Pilot Program Covington & Burling LLP
Aug
8
2017
EU Policy Update, August 2017: Tech and Digital Single Market Policies; Communication and Media Policies; Energy and Environment Policies; Internal Market and Financial Services Policies; Life Sciences and Healthcare Covington & Burling LLP
May
17
2014
The European Commission Launches a Public Consultation on a EU Nano-Registry Covington & Burling LLP
Aug
19
2014
FDA Issues Final Guidance on "In Vitro Companion Diagnostic Devices" Covington & Burling LLP
Sep
9
2014
FTC Brings its First Post-Actavis Suit re: Pharmaceutical Patent Litigation Covington & Burling LLP
Sep
22
2014
Major Damages Award in Pelvic Mesh Case Underscores the Critical Role of Internal Email in Jury Trials Covington & Burling LLP
Jan
13
2015
CDRH Releases 2015 Guidance Document Agenda, Announces Retrospective Guidance Document Review -- Center for Devices and Radiological Health Covington & Burling LLP
Mar
26
2015
European Food Safety Authority (EFSA) Grants Public Access to Data through Scientific “Data Warehouse” Covington & Burling LLP
Apr
29
2015
German Federal Supreme Court Confirms Successor Liability for Coffee Roasters in Spite of Corporate Restructuring Covington & Burling LLP
Oct
23
2015
FDA’s Office of Planning Issues Report on Review Process for Combination Products Covington & Burling LLP
Feb
13
2016
CMA Fines GlaxoSmithKline and Several Generic Companies £45 million for Delaying Market Entry of Generic Paroxetine in the UK Covington & Burling LLP
Feb
22
2016
The UK Psychoactive Substances Act 2016: An Example of Poor Drafting and Unintended Consequences for Food? Covington & Burling LLP
Aug
5
2016
FDA Finalizes General Wellness Guidance Covington & Burling LLP
Oct
17
2016
Italy’s AGCM Market Competition Authority Fines Aspen EUR 5 Million for Excessive Pricing Covington & Burling LLP
Dec
8
2016
UK Competition and Markets Authority Imposes Record Fine on Pfizer Covington & Burling LLP
Apr
30
2017
The Week Ahead in the European Parliament – April 28, 2017 Covington & Burling LLP
Jul
26
2017
Senate Armed Services Committee Directs DoD to Reduce Drug Prices Covington & Burling LLP
Aug
1
2017
The Congressional Agenda for August Covington & Burling LLP
Oct
9
2017
FDA Draft Guidance Addresses Medical Device Status of Microneedling Products Covington & Burling LLP
Apr
6
2018
The Week Ahead in the European Parliament – April 6, 2018 Covington & Burling LLP
Jul
28
2014
FDA Denies Citizen Petition’s Request to Ban Marketing of Non-Absorbable Surgical Mesh Products for Transvaginal Repair of Pelvic Organ Prolapse Covington & Burling LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins